1-3 of 3
Songmao Zheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ADG153, an Anti-CD47 Monoclonal Antibody Prodrug, Has Strong In Vivo Anti-Tumor Activity, Minimal RBC-Related and Antigen Sink Liabilities, and Extended Half Life in Comparison with Benchmark Clinical Antibodies of the Same IgG Subclass

Bin Cai, Aaron N Nguyen, Songmao Zheng, Jianfeng Shi, Guizhong Liu, Yan Li, Felix Du, Peter Luo, Jiangchun Xu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3342.
https://doi.org/10.1182/blood-2021-152130
Published: 2021
Journal Articles

ADG152, a Novel CD20xCD3 T Cell Engager Prodrug with Enhanced Therapeutic Index, Demonstrates Strong Anti-Tumor Activity with Improved Safety

Bin Cai, Aaron N Nguyen, Songmao Zheng, Jianfeng Shi, Guizhong Liu, Yan Li, Felix Du, Stanley Frankel, Peter Luo, Jiangchun Xu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1204.
https://doi.org/10.1182/blood-2021-147573
Published: 2021
Journal Articles

Epo-Independent Proliferation and Differentiation of Genetically Modified Erythroid Progenitor Cells Using a Chemical Inducer of Dimerization.

Chris P. Miller, PhD, Songmao Zheng, C. Anthony Blau, MD
Journal: Blood
Blood (2006) 108 (11): 1159.
https://doi.org/10.1182/blood.V108.11.1159.1159
Published: 2006